[HTML][HTML] SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?

S Chakraborty, V Mallajosyula, CM Tato, GS Tan… - Advanced drug delivery …, 2021 - Elsevier
The ongoing SARS-CoV-2 pandemic has led to the focused application of resources and
scientific expertise toward the goal of developing investigational vaccines to prevent COVID …

[HTML][HTML] Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines

KL Flanagan, E Best, NW Crawford, M Giles… - Frontiers in …, 2020 - frontiersin.org
There are currently around 200 SARS-CoV-2 candidate vaccines in preclinical and clinical
trials throughout the world. The various candidates employ a range of vaccine strategies …

Racing to immunity: Journey to a COVID‐19 vaccine and lessons for the future

E Calvo Fernández, LY Zhu - British journal of clinical …, 2021 - Wiley Online Library
SARS‐CoV‐2 is the novel coronavirus behind the COVID‐19 pandemic. Since its
emergence, the global scientific community has mobilized to study this virus, and an …

COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies

K Rawat, P Kumari, L Saha - European journal of pharmacology, 2021 - Elsevier
Coronavirus Disease 2019 named as COVID-19 imposing a huge burden on public health
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection

CJ Batty, MT Heise, EM Bachelder… - Advanced drug delivery …, 2021 - Elsevier
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has led to an unprecedented effort toward the development of an effective …

SARS-CoV-2 vaccine development: an overview and perspectives

Y Liu, K Wang, TF Massoud… - ACS Pharmacology & …, 2020 - ACS Publications
Coronavirus disease 2019, abbreviated as COVID-19, is caused by a new strain of
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …

[HTML][HTML] Targets and strategies for vaccine development against SARS-CoV-2

JA Malik, AH Mulla, T Farooqi, FH Pottoo… - Biomedicine & …, 2021 - Elsevier
Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …

SARS-CoV-2 vaccine development: current status

GA Poland, IG Ovsyannikova, SN Crooke… - Mayo Clinic …, 2020 - Elsevier
In the midst of the severe acute respiratory syndrome coronavirus 2 pandemic and its
attendant morbidity and mortality, safe and efficacious vaccines are needed that induce …

COVID-19 vaccines: The status and perspectives in delivery points of view

JY Chung, MN Thone, YJ Kwon - Advanced drug delivery reviews, 2021 - Elsevier
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …

[HTML][HTML] The 2020 pandemic: current SARS-CoV-2 vaccine development

SO Alturki, SO Alturki, J Connors, G Cusimano… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome
infecting animals and humans. Coronaviruses have been described more than 70 years ago …